MFAP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.955600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.295800E-01
Normal-vs-Stage2
9.028800E-01
Normal-vs-Stage3
1.486150E-01
Normal-vs-Stage4
5.570600E-01
Stage1-vs-Stage2
6.597800E-01
Stage1-vs-Stage3
1.538190E-01
Stage1-vs-Stage4
5.787400E-01
Stage2-vs-Stage3
3.693600E-01
Stage2-vs-Stage4
3.011400E-01
Stage3-vs-Stage4
1.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.486200E-01
Normal-vs-AfricanAmerican
6.862400E-01
Normal-vs-Asian
5.435800E-01
Caucasian-vs-AfricanAmerican
2.321800E-01
Caucasian-vs-Asian
3.556400E-01
AfricanAmerican-vs-Asian
2.218600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.586400E-01
Normal-vs-Female
9.616200E-01
Male-vs-Female
5.651200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.804600E-01
Normal-vs-Age(41-60Yrs)
6.067000E-01
Normal-vs-Age(61-80Yrs)
7.137200E-01
Normal-vs-Age(81-100Yrs)
2.668800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.129000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.399400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.602800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.359000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.030450E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.068200E-01
Normal-vs-Daily Drinker
2.812200E-01
Normal-vs-Weekly Drinker
6.573000E-01
Normal-vs-Occasional Drinker
9.758400E-01
Normal-vs-Social Drinker
8.131200E-01
Non Drinker-vs-Daily Drinker
5.785000E-01
Non Drinker-vs-Weekly Drinker
5.405800E-01
Non Drinker-vs-Occasional Drinker
1.800390E-01
Non Drinker-vs-Social Drinker
1.221830E-01
Daily Drinker-vs-Weekly Drinker
3.066000E-01
Daily Drinker-vs-Occasional Drinker
1.018020E-01
Daily Drinker-vs-Social Drinker
6.870000E-02
Weekly Drinker-vs-Occasional Drinker
5.527200E-01
Weekly Drinker-vs-Social Drinker
3.103200E-01
Occasional Drinker-vs-Social Drinker
6.268800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.871200E-01
Normal-vs-Grade 2
1.060750E-01
Normal-vs-Grade 3
1.179640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.780820E-01
Grade 1-vs-Grade 3
2.891400E-01
Grade 1-vs-Grade 4
2.871200E-01
Grade 2-vs-Grade 3
8.447800E-01
Grade 2-vs-Grade 4
1.060750E-01
Grade 3-vs-Grade 4
1.179640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.564200E-01
Normal-vs-NonDiabetic
7.484800E-01
Diabetic-vs-NonDiabetic
6.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.144600E-01
Normal-vs-NoPancreatitis
7.683400E-01
Pancreatitis-vs-NoPancreatitis
4.469200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.234800E-01
Normal-vs-N1
9.462200E-01
N0-vs-N1
5.179200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.815400E-01
Normal-vs-TP53-NonMutant
9.450800E-01
TP53-Mutant-vs-TP53-NonMutant
5.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
